TSS:Hg 102066.1

Basic information about the TSS

---

TSS ID: hg_102066.1 Species: human Chr: chr9		Start: 112332949 End: 112333036 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000458258.5 ENST00000210227.4 BC044585 Distance: 0 GeneID: 9991 HGNC/MGI_ID: HGNC:10253 UniProt_ID: O95758 X6R242

Gene_name: polypyrimidine tract binding protein 3 Gene_symbol: PTBP3 Gene_synonyms: DKFZp781I1117 Gene_source: HGNC:10253

TATA-Box annotation

---

Distance to TSS:	33
Nearest PromoterID:	NM_001244898
Entrez ID:	9991
Nearest Unigene:	Hs.269988
Nearest Refseq:	NM_005156
Nearest Ensembl:	ENSG00000119314
Gene Name:	polypyrimidine tract binding protein 3
Gene Alias:	ROD1
Gene Description:	polypyrimidine tract binding protein 3
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.761194
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTBP3 p2@PTBP3 p3@PTBP3 p10@PTBP3
Sample		p1@PTBP3	p2@PTBP3	p3@PTBP3	p10@PTBP3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.42	11.69	0.58	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.40	10.93	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.36	12.15	0.77	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.47	13.31	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	15.97	11.02	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.61	11.82	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.57	11.98	0.87	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.07	12.60	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	15.39	9.83	1.07	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.97	16.81	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.77	16.17	1.21	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.55	18.29	1.63	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.05	4.19	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.21	3.31	1.20	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.27	3.51	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.89	2.26	1.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.50	2.62	1.09	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	20.67	4.22	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.86	5.33	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.82	3.31	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.20	3.74	1.87	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.13	3.11	1.21	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.55	3.36	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.27	2.67	0.49	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	30.44	4.13	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.51	2.53	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.28	3.85	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	3.77	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.74	3.72	1.13	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.88	3.62	1.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.38	4.19	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.30	2.74	1.17	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.16	2.32	1.48	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	19.46	2.14	1.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.89	3.93	2.43	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.20	3.26	1.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.62	4.09	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.53	3.02	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.23	4.32	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.24	3.36	1.68	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	17.64	2.35	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.08	3.37	0.88	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.62	3.80	1.48	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	21.68	4.37	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.29	3.21	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	25.59	3.95	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.79	5.28	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.18	3.28	1.49	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.54	3.83	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	29.93	5.26	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.15	6.97	0.61	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.25	6.45	1.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	6.74	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.49	5.96	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	8.39	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.99	2.76	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	32.73	4.54	1.94	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	25.37	3.21	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	29.55	8.49	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	6.35	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.38	6.73	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	14.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	33.64	10.53	1.36	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	49.71	11.70	2.60	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	38.34	9.58	0.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	37.05	9.75	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	50.08	10.41	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	54.89	12.20	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.37	15.57	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	44.85	12.37	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	49.22	11.31	1.53	0.31
Adipocyte - breast, donor1	11376-118A8	33.74	7.29	0.48	0.95
Adipocyte - breast, donor2	11327-117E4	19.25	3.21	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	44.53	11.07	0.64	1.02
Adipocyte - omental, donor2	11474-119C7	24.67	2.24	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	18.09	3.01	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.86	3.19	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	7.70	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	1.35	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	6.95	0.70	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	35.79	8.41	0.39	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	29.08	7.72	0.77	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	28.71	8.08	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	0.59	1.18	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	25.90	11.58	1.85	1.77
Adipocyte differentiation, day08, donor2	13023-139D8	25.82	7.75	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	20.26	9.06	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	3.34	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	18.72	4.16	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	22.10	6.53	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	22.58	6.87	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	14.61	6.70	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	19.45	10.39	0.22	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	16.85	6.45	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	34.54	11.87	0.36	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	1.67	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	20.96	5.55	0.62	0.41
Anulus Pulposus Cell, donor1	11248-116E6	13.27	1.95	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	16.65	0.98	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	6.29	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.88	3.04	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	4.48	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	4.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.22	4.55	0.97	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.59	3.40	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	2.97	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	4.90	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	3.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	6.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.45	5.27	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.29	5.58	1.06	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.36	6.97	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	3.97	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.11	5.08	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	7.80	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.42	3.65	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.95	4.63	0.51	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	4.17	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	6.06	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.66	4.56	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.39	4.06	1.50	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.71	3.61	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.95	5.16	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	1.93	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	4.99	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	2.34	1.75	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.38	3.61	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	2.54	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.06	4.08	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	3.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	3.45	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.72	4.02	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.95	4.35	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	4.72	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.14	4.07	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.30	3.43	0.86	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.83	7.82	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	6.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.24	4.83	0.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.78	7.63	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.23	8.46	0.21	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.22	5.20	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	3.35	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.07	6.21	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.62	3.88	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.62	5.30	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.54	6.18	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	22.35	2.21	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	21.22	2.40	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.49	0.84	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	25.80	4.18	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	25.56	3.24	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	29.09	5.22	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	88.31	18.01	4.01	4.70
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	94.46	22.80	2.63	3.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	91.49	22.30	2.84	3.64
Basophils, donor1	12241-129G9	77.68	13.60	0.78	3.40
Basophils, donor2	12242-129H1	155.14	19.84	1.44	6.13
Basophils, donor3	12243-129H2	106.72	11.47	0.73	5.44
Bronchial Epithelial Cell, donor1	11511-119G8	19.19	4.10	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	25.15	2.74	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	39.54	8.16	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	32.86	3.95	1.04	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	27.63	5.99	0.23	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	41.93	5.40	1.80	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	79.56	15.56	3.30	3.61
Burkitt's lymphoma cell line:RAJI	10476-106I8	86.64	17.00	5.82	3.03
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	72.91	12.15	2.24	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	105.38	16.34	1.13	4.51
CD14+ Monocytes, donor2	11305-117B9	119.71	15.59	1.86	5.94
CD14+ Monocytes, donor3	11381-118B4	98.13	9.44	2.63	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	135.86	21.79	0.28	4.25
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	125.47	18.57	0.76	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	163.38	32.22	2.63	6.25
CD14+ monocytes - mock treated, donor1	11863-125A9	112.31	17.35	0.29	6.94
CD14+ monocytes - mock treated, donor2	11873-125C1	74.23	12.97	0.60	5.13
CD14+ monocytes - mock treated, donor3	11883-125D2	112.52	17.53	0.47	5.45
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	81.86	14.40	0.17	4.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	66.24	16.01	1.10	4.14
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	72.15	23.55	0.25	3.47
CD14+ monocytes - treated with BCG, donor1	11860-125A6	74.99	12.14	0.39	3.92
CD14+ monocytes - treated with BCG, donor2	11870-125B7	80.83	14.24	0.53	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	80.09	19.59	0.22	3.70
CD14+ monocytes - treated with Candida, donor1	11868-125B5	82.18	14.75	1.17	4.21
CD14+ monocytes - treated with Candida, donor2	11878-125C6	91.88	10.56	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	82.09	21.08	0.00	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	87.61	14.87	0.15	4.46
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	62.06	13.37	0.20	3.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	62.04	19.36	0.00	4.79
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	82.36	16.70	0.46	4.80
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	65.60	18.55	0.90	4.07
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	63.29	15.71	0.87	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	107.33	16.14	1.08	5.65
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	105.20	16.05	0.17	3.84
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	123.30	14.31	0.42	5.05
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	82.49	24.07	0.18	3.67
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	53.90	19.73	1.76	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	75.02	33.34	0.88	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	83.35	13.78	0.35	4.01
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	69.13	9.66	0.00	6.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	81.91	16.81	0.22	6.90
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	75.76	22.93	0.00	5.32
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	59.57	20.63	0.46	3.94
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	71.45	35.96	1.39	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	74.76	14.60	0.44	5.67
CD14+CD16+ Monocytes, donor2	11801-124D1	100.25	16.17	0.00	4.39
CD14+CD16+ Monocytes, donor3	11912-125G4	66.72	10.40	0.65	5.20
CD14+CD16- Monocytes, donor1	11788-124B6	177.68	24.92	0.78	11.06
CD14+CD16- Monocytes, donor2	11799-124C8	129.94	20.96	0.52	10.30
CD14+CD16- Monocytes, donor3	11910-125G2	184.84	30.10	0.67	10.48
CD14-CD16+ Monocytes, donor1	11790-124B8	100.79	15.57	0.77	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	106.49	18.00	0.00	5.71
CD14-CD16+ Monocytes, donor3	11911-125G3	85.27	18.74	0.21	3.58
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	164.62	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	134.92	4.75	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	124.27	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	121.00	9.59	0.00	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	129.73	7.50	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	127.05	4.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	125.50	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	130.51	3.95	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	189.04	9.04	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	129.85	4.35	1.45	3.63
CD19+ B Cells, donor3	11705-123B4	157.00	6.06	0.50	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	81.62	16.97	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.12	14.78	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	98.40	7.03	2.01	3.01
CD34+ Progenitors, donor2	11625-122B5	97.19	9.55	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	75.15	15.03	1.50	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	76.21	16.69	2.25	1.80
CD4+ T Cells, donor1	11225-116C1	220.66	5.00	2.14	1.43
CD4+ T Cells, donor2	11306-117C1	156.76	4.90	3.06	0.61
CD4+ T Cells, donor3	11382-118B5	179.03	6.10	2.44	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	166.67	7.15	8.68	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	151.60	3.82	5.84	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	164.71	3.16	5.17	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	127.06	3.32	2.37	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	115.88	6.32	3.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	122.69	14.74	5.35	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	147.94	5.93	8.47	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	149.28	9.19	7.74	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	147.49	3.59	1.79	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	137.66	6.29	2.10	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	136.39	6.60	1.32	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	148.42	13.91	3.79	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	143.98	10.80	2.49	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	134.99	9.02	4.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	150.65	1.90	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	152.21	3.75	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	132.70	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	187.28	15.39	3.89	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	146.00	11.05	3.03	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	180.10	14.08	6.09	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	117.81	6.57	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	123.91	3.47	1.73	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	121.16	2.18	3.49	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	151.43	6.93	0.99	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	139.40	2.77	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	142.37	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	162.00	6.65	1.38	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	213.98	5.64	0.98	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	178.64	7.70	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	155.78	5.37	1.43	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	160.66	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	194.47	7.20	1.31	1.64
CD8+ T Cells, donor2	11307-117C2	176.08	4.13	2.63	0.75
CD8+ T Cells, donor3	11383-118B6	172.45	6.31	2.27	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.01	3.21	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.86	4.07	0.00	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	20.52	5.20	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.41	4.50	0.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.60	4.80	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.96	5.68	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.60	6.74	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.58	8.16	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.00	6.10	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.32	5.43	0.30	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.40	5.81	0.00	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.65	6.93	0.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.33	20.57	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.13	18.22	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.09	20.88	2.24	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.52	4.32	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.54	4.60	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.26	4.48	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.23	5.70	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	17.53	7.38	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.91	5.77	0.00	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.65	5.35	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	8.28	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	5.29	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	24.89	2.41	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	30.08	3.50	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	28.05	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	67.63	7.31	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	27.17	7.41	1.48	1.48
Cardiac Myocyte, donor3	11686-122I3	31.89	7.58	0.63	0.42
Chondrocyte - de diff, donor1	11261-116G1	31.20	9.36	0.69	1.39
Chondrocyte - de diff, donor2	11338-117F6	14.57	6.04	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	15.93	6.37	0.91	0.57
Chondrocyte - re diff, donor2	11339-117F7	27.75	6.27	0.00	2.69
Chondrocyte - re diff, donor3	11411-118E7	30.33	3.64	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	42.92	9.07	0.34	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	35.27	6.84	0.64	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	41.42	6.46	0.44	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	69.97	14.31	4.13	1.38
Corneal Epithelial Cells, donor1	11526-119I5	18.00	4.61	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	30.72	5.69	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	29.65	4.09	2.05	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	96.25	47.22	2.15	7.92
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	85.16	44.16	1.89	7.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	48.31	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	65.87	35.10	0.76	4.21
Dendritic Cells - plasmacytoid, donor1	11228-116C4	230.61	118.21	12.98	7.52
Dendritic Cells - plasmacytoid, donor2	11309-117C4	166.48	111.64	7.83	5.88
Dendritic Cells - plasmacytoid, donor3	11385-118B8	184.38	89.05	15.97	10.16
Endothelial Cells - Aortic, donor0	11207-116A1	33.52	7.00	0.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	4.11	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	24.32	3.11	0.28	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	4.72	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	17.45	5.24	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	34.35	6.59	0.24	2.35
Endothelial Cells - Artery, donor3	11413-118E9	26.47	5.08	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	44.77	4.65	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	56.90	8.22	0.61	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	68.50	10.99	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	34.76	5.35	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	26.03	6.77	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	22.83	2.69	0.14	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	68.42	18.81	1.20	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	19.92	3.14	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	79.27	12.55	0.99	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	62.35	4.78	0.43	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	72.79	10.50	0.24	1.95
Endothelial Cells - Vein, donor1	11267-116G7	15.93	4.55	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	3.49	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	38.15	3.77	0.47	1.10
Eosinophils, donor1	12244-129H3	213.46	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	504.98	57.76	3.30	8.25
Eosinophils, donor3	12246-129H5	356.68	32.10	0.00	17.83
Esophageal Epithelial Cells, donor1	11507-119G4	20.28	3.91	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	52.96	11.49	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.04	5.47	0.44	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.64	4.23	0.22	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.53	9.22	0.73	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.52	19.38	1.09	1.77
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.46	5.48	0.32	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	31.88	3.69	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.24	5.65	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	18.60	10.89	2.27	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	3.03	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.77	6.78	0.32	1.10
Fibroblast - Cardiac, donor4	11452-119A3	44.56	5.46	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	45.94	7.11	0.63	1.02
Fibroblast - Cardiac, donor6	11460-119B2	42.14	7.58	0.61	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	28.00	5.23	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.61	5.18	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	17.76	7.84	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	27.31	3.05	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	11.03	1.41	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	13.68	0.47	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	11.48	1.33	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	38.55	5.20	0.79	0.45
Fibroblast - Dermal, donor5	11454-119A5	43.61	4.88	0.87	0.87
Fibroblast - Dermal, donor6	11458-119A9	47.59	5.36	0.16	0.81
Fibroblast - Gingival, donor1	11237-116D4	25.61	6.04	0.62	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.73	9.69	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	32.29	4.74	0.53	0.92
Fibroblast - Gingival, donor3	11394-118C8	27.75	4.35	0.48	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	10.39	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.67	7.58	0.70	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	52.38	17.77	1.56	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.54	10.01	0.54	1.76
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	54.34	18.00	2.47	2.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.55	17.99	1.17	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	40.91	12.54	0.82	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	63.95	34.44	0.66	3.51
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.22	12.47	0.29	1.76
Fibroblast - Lung, donor1	11270-116H1	9.52	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	4.48	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	17.73	1.06	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	33.32	8.33	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	19.58	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	7.28	1.96	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	37.35	9.34	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	35.30	5.24	0.58	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.66	3.64	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	53.55	9.18	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	31.29	8.40	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.99	17.28	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	29.11	9.28	0.35	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.53	9.40	0.55	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	28.24	11.18	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	2.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.79	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.44	10.32	0.40	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.24	9.06	0.53	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.14	17.54	0.00	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.89	3.91	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	36.06	9.82	0.65	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	41.50	8.10	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	31.50	6.56	0.66	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.10	7.82	0.40	1.00
Fibroblast - skin normal, donor2	11561-120D4	32.35	5.42	0.40	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.66	11.18	0.60	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	37.61	15.82	0.58	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.84	3.42	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.27	5.58	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.68	7.24	0.32	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	19.23	7.59	0.34	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.98	8.63	0.16	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	210.04	60.14	6.97	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	51.66	22.54	1.91	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	72.61	24.46	1.56	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	74.61	30.92	3.07	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.76	8.42	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.67	10.85	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	95.85	17.40	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	86.59	13.51	0.28	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	64.39	9.36	2.05	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	80.04	17.44	1.19	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	83.53	15.60	0.26	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	69.14	14.02	2.94	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	89.77	23.44	2.65	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	57.80	13.43	1.84	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.90	13.18	3.08	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.20	14.24	0.81	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	58.60	14.25	1.36	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	91.64	25.06	1.66	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	62.82	24.19	1.42	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.29	11.41	1.37	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.41	14.20	1.00	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	97.27	17.92	2.19	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	44.03	7.98	1.48	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.71	7.47	1.59	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	66.13	18.32	2.23	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.83	8.07	0.40	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.79	5.94	1.02	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	73.78	30.24	2.75	2.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.56	12.80	1.25	3.12
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.60	9.73	0.68	2.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.52	5.98	0.55	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.16	15.64	1.33	2.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.22	17.76	0.61	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.50	6.81	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.94	6.23	0.23	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.85	7.50	0.33	2.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.44	5.29	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	34.19	4.67	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.69	8.92	0.32	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.05	6.41	0.96	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.66	4.17	0.47	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.26	7.75	0.47	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.67	6.08	0.30	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.81	5.33	0.94	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	33.59	5.49	1.10	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.58	5.33	0.84	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.20	7.50	0.56	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.26	9.36	0.80	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.38	9.64	0.46	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.63	5.70	0.26	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.43	7.59	1.08	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	37.05	10.88	0.92	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.24	5.48	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	65.46	15.87	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.15	6.46	0.66	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.04	5.04	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.29	17.54	1.52	3.56
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	88.58	24.29	2.19	3.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	71.80	15.72	1.85	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	74.26	15.14	2.86	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.11	11.58	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	30.80	9.32	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.25	10.15	2.77	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	9.90	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	45.26	13.93	0.77	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	8.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	8.69	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	35.80	10.74	1.63	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	48.59	9.47	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	39.43	10.91	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.32	10.13	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	5.87	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.94	8.91	0.64	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.40	11.21	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	40.09	6.87	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.89	5.92	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	20.33	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	25.68	10.77	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.14	8.98	0.69	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	20.76	10.38	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.27	9.45	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.10	6.02	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	28.51	5.39	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	38.34	11.64	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	7.45	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.02	6.13	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	43.45	5.43	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.13	7.63	3.56	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	50.65	5.18	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	40.95	8.88	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	14.17	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	43.18	6.42	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.52	3.95	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	28.82	7.63	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.10	4.78	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	22.32	6.79	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	9.13	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.05	7.07	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	4.50	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.91	3.49	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	2.51	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.97	17.64	1.04	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	34.77	18.74	1.86	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.17	17.97	1.14	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.79	17.05	1.42	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.96	16.33	0.86	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.20	19.59	0.43	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	37.61	16.19	1.37	1.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	32.94	20.24	0.51	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.31	15.70	2.24	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	32.46	5.60	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	3.46	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.16	6.00	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.25	5.25	0.35	0.52
Hepatocyte, donor1	11523-119I2	20.58	8.47	1.21	0.00
Hepatocyte, donor2	11603-120I1	29.09	9.70	1.08	2.15
Hepatocyte, donor3	11684-122I1	20.25	6.75	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	80.28	10.44	8.48	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	112.91	69.39	3.85	2.80
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.03	7.00	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	27.08	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	8.31	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	56.85	9.75	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	11.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	39.70	15.88	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	24.39	11.09	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.86	9.45	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	9.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.30	9.04	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	14.49	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	8.15	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.47	7.98	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	45.81	12.06	2.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.93	11.08	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.30	5.66	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	8.16	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	10.76	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	8.89	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.88	7.65	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	9.11	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	7.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	6.64	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	21.30	5.56	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	14.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	32.68	12.52	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	15.49	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	12.97	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	56.68	10.46	5.23	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	18.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	21.34	4.27	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	12.47	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	14.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	36.82	10.12	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	15.13	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	43.46	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	44.41	16.92	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	51.16	15.42	2.53	0.82
Keratinocyte - epidermal, donor2	11349-117G8	18.74	5.27	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	62.85	9.84	1.80	0.66
Keratinocyte - oral, donor1	11251-116E9	86.05	13.74	4.88	0.79
Keratocytes, donor1	11527-119I6	20.29	8.60	0.00	0.34
Keratocytes, donor2	11607-120I5	19.92	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	25.69	1.58	0.20	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	81.32	43.96	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	30.20	4.31	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	23.41	1.50	0.58	0.46
Lens Epithelial Cells, donor3	11690-122I7	36.53	6.36	0.40	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	31.78	6.76	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.00	4.74	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.69	6.45	0.31	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.27	3.23	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	30.57	6.30	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.16	2.05	0.00	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	39.40	6.98	0.00	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.41	3.03	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.63	3.52	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.66	8.70	0.79	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	36.64	5.62	0.58	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.59	1.67	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.43	4.53	0.35	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.20	4.53	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.60	2.20	0.14	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.72	7.70	0.00	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.02	3.43	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.07	2.38	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.91	3.62	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	0.88	0.00	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.19	2.74	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	6.30	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.62	4.31	0.54	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.49	2.88	0.15	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	7.78	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	42.09	8.38	1.26	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.36	2.11	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	8.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.85	6.96	0.38	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.84	2.97	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	7.27	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	28.12	6.62	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.59	3.47	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.83	11.85	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.48	7.41	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.85	2.61	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	6.75	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.04	10.04	0.30	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.25	5.88	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	30.22	3.91	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.00	7.27	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.36	2.33	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.93	3.94	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.79	6.21	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.71	1.65	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.43	11.76	0.37	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.16	5.63	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	16.11	1.49	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	15.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.86	6.14	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	4.45	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	50.35	8.04	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	38.68	7.74	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	7.47	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.86	5.15	0.52	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.46	9.27	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	63.98	12.80	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.07	11.25	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.83	12.33	0.81	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.65	12.32	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.58	13.41	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	47.97	8.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	13.24	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	56.30	9.34	0.53	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	59.14	10.77	0.19	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.86	8.59	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	6.52	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	60.81	8.75	0.83	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.86	12.33	0.28	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	41.21	14.42	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	53.13	11.03	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	62.48	14.65	1.20	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	59.75	17.15	0.00	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	48.43	10.60	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	57.53	12.17	0.37	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	40.29	8.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.29	8.83	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	46.42	11.32	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	49.23	8.20	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	39.77	8.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	48.83	10.77	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	55.27	11.95	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	47.19	10.40	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	61.17	12.06	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	5.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.64	6.00	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	63.35	12.07	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.84	4.98	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	44.34	9.97	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.92	11.81	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	43.77	6.73	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.04	8.15	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	11.63	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	39.14	3.17	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.42	6.40	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	57.42	9.45	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	36.79	8.43	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	9.87	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	9.41	0.94	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	44.75	9.55	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	47.77	8.56	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	43.03	10.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.21	12.02	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	44.97	10.56	1.17	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	45.52	10.56	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	50.34	6.23	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.88	9.63	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	59.26	14.54	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	45.93	13.25	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	49.76	10.80	0.39	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	59.75	9.11	2.03	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	44.22	12.98	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	45.72	10.34	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	46.79	6.08	0.00	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	38.04	10.38	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	53.58	10.64	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	9.81	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.60	8.47	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.63	10.14	0.95	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	49.04	8.53	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	46.55	6.32	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.97	7.71	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	39.61	9.20	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	50.51	9.65	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	46.18	9.57	0.42	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	46.98	11.75	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	47.18	5.43	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	38.10	10.22	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	49.51	8.70	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	57.21	9.09	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	34.35	10.10	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	4.59	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.90	8.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	48.44	11.40	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	38.34	8.44	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.81	10.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	47.66	8.46	0.89	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	47.57	13.00	1.04	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	54.37	13.26	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	8.31	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	101.88	19.83	2.05	1.60
Macrophage - monocyte derived, donor2	11313-117C8	57.25	24.77	0.73	2.39
Macrophage - monocyte derived, donor3	11389-118C3	78.52	16.52	1.57	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	27.61	17.52	3.19	1.59
Mallassez-derived cells, donor2	11929-125I3	49.44	38.03	3.96	2.22
Mallassez-derived cells, donor3	11930-125I4	50.73	30.72	1.81	1.11
Mammary Epithelial Cell, donor1	11273-116H4	68.06	22.32	4.09	2.09
Mammary Epithelial Cell, donor2	11350-117G9	60.52	20.85	4.05	1.45
Mammary Epithelial Cell, donor3	11422-118F9	26.94	4.99	1.75	0.50
Mast cell - stimulated, donor1	11487-119E2	314.56	128.13	3.39	9.49
Mast cell, donor1	11563-120D6	110.63	11.79	1.73	2.81
Mast cell, donor2	11565-120D8	173.25	9.81	1.19	6.54
Mast cell, donor3	11566-120D9	194.28	16.21	3.83	6.98
Mast cell, donor4	11567-120E1	172.33	11.88	1.77	7.45
Mast cell, expanded and stimulated, donor5	11940-126A5	80.84	15.86	0.44	4.44
Mast cell, expanded and stimulated, donor8	11942-126A7	57.20	13.42	0.58	9.92
Mast cell, expanded, donor5	11939-126A4	94.76	10.10	0.57	3.44
Mast cell, expanded, donor8	11941-126A6	111.97	14.73	2.34	6.19
Melanocyte - dark, donor1	11502-119F8	50.25	6.96	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	27.34	9.34	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	30.43	6.66	0.51	0.80
Melanocyte - light, donor1	11274-116H5	11.99	3.76	0.24	0.94
Melanocyte - light, donor2	11351-117H1	5.46	1.36	0.68	0.68
Melanocyte - light, donor3	11423-118G1	5.20	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.24	4.37	0.10	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	25.28	6.19	0.27	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	21.43	8.84	1.34	1.07
Meningeal Cells, donor1	11493-119E8	35.61	5.83	0.25	0.37
Meningeal Cells, donor2	11573-120E7	29.05	2.20	0.44	0.44
Meningeal Cells, donor3	11654-122E7	40.67	8.80	0.49	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	25.95	5.13	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.26	10.77	0.50	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	5.74	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.99	4.66	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	5.03	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.98	5.93	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	5.11	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.19	5.32	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.38	5.26	0.28	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	1.86	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.39	6.58	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.64	0.89	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	16.65	2.56	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.38	8.86	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.70	2.50	0.63	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	11.61	3.63	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	19.89	10.61	1.06	0.80
Mesothelial Cells, donor2	12156-128G5	18.52	7.01	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	27.53	7.80	0.51	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	13.50	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	73.64	22.90	0.99	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	64.78	16.78	1.18	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	76.06	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	65.40	20.77	1.24	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.75	16.18	0.00	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	0.00	2.32	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	60.06	17.02	1.00	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.12	19.55	1.86	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	54.46	18.49	0.61	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	43.16	14.25	1.19	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	47.79	24.78	0.88	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.51	9.88	0.00	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	57.90	6.58	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	59.42	21.22	1.49	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	32.23	6.45	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	56.93	17.88	1.49	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	5.03	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	47.92	21.33	0.25	2.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	40.64	16.64	0.48	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	44.23	17.14	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	47.20	26.02	0.46	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	53.43	16.83	0.63	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	50.55	31.19	1.02	2.65
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	50.20	25.74	1.50	2.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	47.57	17.34	0.67	1.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	47.09	32.41	1.53	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	49.17	17.24	1.01	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	62.97	8.28	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	47.56	44.30	0.82	3.53
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	53.82	27.35	0.29	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	14.17	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	42.77	41.33	1.44	4.32
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	58.43	30.82	1.60	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	16.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	49.56	49.06	1.00	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	16.31	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	63.50	35.03	2.19	7.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	33.11	11.04	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.74	24.33	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	56.77	47.60	1.49	3.22
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	47.32	16.70	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	24.31	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	39.66	34.53	0.00	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	42.45	17.07	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	37.29	20.60	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	47.41	41.24	0.56	4.21
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	49.04	24.52	0.42	4.16
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.89	23.31	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.53	32.28	0.90	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.59	25.88	1.25	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	36.09	7.22	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	52.64	24.94	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	50.65	21.06	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	49.33	22.11	0.55	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	44.57	31.62	0.52	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	40.75	21.02	1.72	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.75	13.34	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.04	20.55	0.53	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	68.85	23.35	2.10	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.50	16.67	0.99	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.68	28.03	1.91	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.61	24.55	1.11	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	44.75	15.17	0.38	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	55.97	38.35	0.85	2.56
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	54.57	24.58	0.74	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.89	14.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	61.16	33.23	1.76	3.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	59.68	21.62	1.73	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	70.89	35.03	1.24	3.30
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	61.34	21.74	2.68	2.98
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	57.03	10.69	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	64.07	24.97	1.64	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	65.22	16.83	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	80.46	17.99	1.98	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	81.02	23.28	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	80.36	31.54	3.76	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.87	16.51	0.80	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	50.22	17.53	0.57	2.15
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	8.84	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	76.22	28.21	2.20	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	63.78	20.22	1.56	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	59.86	25.12	1.60	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	7.73	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	73.73	32.32	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	69.99	18.13	1.69	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	25.88	4.09	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.71	19.07	1.27	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	36.44	27.53	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	19.64	4.53	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	39.97	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	26.10	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	23.76	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.24	12.93	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.70	6.27	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	60.74	4.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	63.44	7.51	1.25	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	39.36	7.23	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	6.38	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.28	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.51	1.26	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	40.21	9.76	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.89	3.24	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.39	3.57	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.82	1.49	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.15	4.60	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.94	4.99	1.59	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.80	3.92	0.16	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.43	4.74	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.87	5.83	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	4.20	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	20.68	7.22	0.98	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.97	8.13	1.46	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	33.69	3.70	0.53	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.91	2.11	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	6.90	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	31.17	9.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	30.35	10.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.41	7.80	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.48	5.50	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.45	5.46	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	7.73	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	37.65	4.00	1.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	4.96	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.79	5.56	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	33.43	3.71	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.89	8.70	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	40.41	14.99	0.65	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.99	6.10	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	4.98	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	8.82	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	30.58	7.31	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	47.12	11.41	0.99	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	42.49	14.93	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.29	3.93	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.40	6.19	0.66	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	7.45	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	51.82	5.49	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	45.95	10.39	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	37.83	5.75	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	35.60	7.91	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	9.07	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	21.12	9.69	0.50	0.75
Myoblast, donor2	11322-117D8	31.84	5.56	0.19	0.58
Myoblast, donor3	11398-118D3	38.00	11.27	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	102.30	21.60	2.48	3.65
Natural Killer Cells, donor1	11230-116C6	190.97	7.69	1.23	3.08
Natural Killer Cells, donor2	11311-117C6	173.09	6.63	3.62	1.21
Natural Killer Cells, donor3	11387-118C1	154.79	7.73	2.76	1.10
Neural stem cells, donor1	11275-116H6	19.96	3.27	0.00	0.73
Neural stem cells, donor2	11352-117H2	53.92	1.93	0.00	1.93
Neurons, donor1	11494-119E9	22.76	1.14	0.00	0.00
Neurons, donor2	11574-120E8	28.18	1.10	0.00	0.22
Neurons, donor3	11655-122E8	29.60	4.93	0.00	0.00
Neutrophils, donor1	11233-116C9	618.05	82.59	1.86	12.99
Neutrophils, donor2	11314-117C9	582.67	57.98	2.90	26.09
Neutrophils, donor3	11390-118C4	1126.39	108.12	2.44	25.66
Nucleus Pulposus Cell, donor1	11252-116F1	25.88	3.21	0.24	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	0.65	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	21.26	0.80	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	37.03	5.92	0.83	0.55
Olfactory epithelial cells, donor2	11934-125I8	40.24	8.54	0.58	0.87
Olfactory epithelial cells, donor3	11935-125I9	36.32	6.47	0.68	0.91
Olfactory epithelial cells, donor4	11936-126A1	51.13	6.23	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	51.15	17.45	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	13.61	3.19	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	11.34	2.35	0.00	0.20
Osteoblast, donor2	11354-117H4	23.18	6.32	0.70	2.11
Osteoblast, donor3	11426-118G4	18.13	4.80	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	23.59	6.15	0.67	0.34
Pericytes, donor1	11491-119E6	8.12	0.22	0.00	0.22
Pericytes, donor2	11571-120E5	11.77	0.23	0.23	0.23
Pericytes, donor3	11652-122E5	20.55	4.68	0.20	0.00
Perineurial Cells, donor1	11499-119F5	31.42	3.96	0.11	0.57
Perineurial Cells, donor2	11579-120F4	42.23	9.11	0.55	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	199.85	14.02	1.59	7.65
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	122.92	10.28	1.96	4.41
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	139.25	8.15	1.42	3.49
Placental Epithelial Cells, donor1	11278-116H9	15.07	6.46	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	21.07	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.56	0.79	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.82	6.01	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	28.89	7.69	0.75	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	28.45	8.22	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	22.29	4.05	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	34.52	12.36	0.85	1.28
Preadipocyte - omental, donor2	11329-117E6	25.32	8.73	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	34.38	9.31	0.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	16.73	3.94	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	7.68	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.81	7.97	0.35	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	19.92	3.24	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	30.74	6.61	0.28	0.47
Preadipocyte - visceral, donor2	11357-117H7	25.31	5.06	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	21.73	3.24	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	75.12	74.97	1.51	5.58
Prostate Epithelial Cells, donor2	11331-117E8	43.20	16.79	2.17	0.95
Prostate Epithelial Cells, donor3	11404-118D9	63.93	11.33	1.53	0.73
Prostate Stromal Cells, donor1	11254-116F3	25.63	7.97	1.03	0.00
Prostate Stromal Cells, donor2	11332-117E9	24.92	6.45	0.54	0.72
Prostate Stromal Cells, donor3	11405-118E1	15.22	3.55	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.75	16.06	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	77.63	40.69	2.50	2.43
Renal Epithelial Cells, donor1	11517-119H5	29.93	14.20	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	28.45	14.94	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	98.03	63.73	1.80	2.54
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	3.40	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	31.53	4.04	0.67	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	59.05	21.54	0.67	2.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	16.64	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.67	14.09	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	31.98	15.05	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	19.42	6.38	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	53.15	20.94	1.07	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.31	15.18	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.64	14.08	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.15	4.41	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.95	1.42	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	21.08	3.51	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	66.02	13.10	1.20	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	17.87	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	59.44	39.63	1.10	5.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	50.46	22.62	1.16	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	84.00	35.89	2.73	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	78.75	35.55	3.18	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	78.41	53.43	2.45	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.87	34.11	3.23	2.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	82.75	40.79	3.73	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	93.61	47.38	3.24	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	71.88	29.57	3.42	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	77.91	39.33	3.48	2.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	82.43	45.87	2.69	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	70.44	25.54	1.15	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	71.47	31.55	2.68	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	75.01	42.71	3.10	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	72.26	24.09	3.25	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	81.33	37.64	2.14	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	90.76	61.63	3.19	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	80.42	31.45	3.32	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	83.03	38.55	2.53	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	79.25	38.96	2.29	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	81.48	32.25	2.24	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	74.00	41.77	1.40	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	80.83	37.60	2.22	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	75.12	30.81	2.55	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	70.27	38.02	1.96	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	74.95	37.88	3.36	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	74.77	29.48	2.36	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	89.29	41.47	2.78	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	78.81	41.62	2.81	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	74.23	29.65	3.11	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	73.44	44.02	1.77	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	87.31	37.39	1.88	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	77.52	24.90	2.29	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	83.10	36.78	3.07	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	84.06	45.89	1.93	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	72.90	24.59	2.75	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	85.18	31.55	2.06	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	80.44	38.25	2.63	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	71.41	24.88	3.07	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	87.15	31.66	1.92	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	77.57	36.25	2.67	2.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	70.10	18.94	0.69	1.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	59.76	28.33	1.19	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	99.56	43.13	3.83	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.24	20.34	2.07	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	81.05	20.96	1.75	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	60.14	23.27	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.11	17.87	1.96	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	114.84	54.15	1.89	5.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	54.76	21.29	3.04	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.46	15.07	0.90	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.94	20.58	2.26	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	64.40	25.76	2.70	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.63	15.00	0.47	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	52.51	21.77	1.92	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	68.51	11.42	3.61	2.40
Schwann Cells, donor1	11498-119F4	16.36	1.50	0.38	0.38
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.47	2.85	0.44	0.22
Sebocyte, donor1	11220-116B5	56.42	15.89	2.74	0.00
Sebocyte, donor2	11301-117B5	32.17	5.97	1.38	0.46
Sebocyte, donor3	11378-118B1	19.79	5.15	1.03	0.41
Sertoli Cells, donor1	11255-116F4	33.13	8.28	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	22.52	4.84	0.53	0.70
Skeletal Muscle Cells, donor2	11358-117H8	4.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.90	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	38.49	5.50	0.94	0.94
Skeletal Muscle Cells, donor5	11455-119A6	37.31	4.16	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	44.17	6.00	0.62	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.72	5.67	0.88	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.67	2.57	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	40.97	7.34	0.20	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.40	5.48	0.25	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	9.41	5.07	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.11	1.65	0.41	0.14
Skin - palm, donor1	10286-104F7	96.70	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	55.07	18.45	3.46	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	176.66	66.25	10.63	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	69.33	24.67	4.41	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	65.89	29.19	1.67	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	68.22	22.65	2.25	2.11
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	189.24	56.88	7.82	4.02
Small Airway Epithelial Cells, donor3	11406-118E2	68.65	16.79	2.92	2.32
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.89	3.09	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	26.01	4.45	0.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	2.35	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.38	3.76	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	1.58	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.05	1.33	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.50	5.76	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	36.23	11.27	1.28	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.77	2.60	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	36.03	7.09	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.74	8.54	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.78	2.11	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.40	2.74	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.16	2.02	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.69	3.81	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.89	5.16	0.15	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.06	4.95	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.60	8.19	0.31	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.13	2.47	0.46	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	2.16	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.75	2.69	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	3.41	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.33	4.71	0.16	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.52	5.54	1.11	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.25	5.69	0.00	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.92	8.21	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.30	5.59	0.80	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.29	7.51	0.88	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.01	2.03	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	24.73	5.43	0.30	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	5.17	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.07	2.79	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	5.05	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.80	8.46	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.78	0.88	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.49	5.66	0.92	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	1.87	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.93	6.48	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.79	5.10	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.46	2.26	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	30.05	5.73	0.70	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	32.51	8.97	0.75	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.54	4.65	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	25.41	7.95	0.44	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.63	2.63	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.08	2.92	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.02	7.40	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	2.60	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	4.31	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.48	6.53	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.84	9.45	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	2.54	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	18.37	1.20	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	4.18	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	14.67	3.21	0.00	0.46
Synoviocyte, donor1	11291-117A4	29.62	14.64	0.34	1.68
Synoviocyte, donor2	11368-117I9	15.25	4.36	0.00	0.34
Synoviocyte, donor3	11440-118H9	17.43	3.80	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	11.79	2.86	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	17.60	2.78	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	42.44	9.75	1.29	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	27.45	6.19	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	23.48	5.73	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	67.42	17.84	1.35	2.95
Urethra, donor2	10319-105A4	59.35	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	26.03	9.03	0.80	0.27
Urothelial Cells, donor2	11600-120H7	28.84	2.00	0.80	1.20
Urothelial Cells, donor3	11681-122H7	29.57	2.98	0.69	0.00
Urothelial cells, donor0	11216-116B1	80.91	13.15	2.01	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	207.32	20.47	3.56	13.35
Whole blood (ribopure), donor090309, donation2	12180-129A2	208.72	21.44	1.43	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	162.23	10.27	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	188.01	16.53	0.69	4.13
Whole blood (ribopure), donor090325, donation2	12177-128I8	194.64	16.85	0.58	6.39
Whole blood (ribopure), donor090612, donation1	12182-129A4	228.03	22.91	3.12	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	189.07	15.60	2.75	7.34
Whole blood (ribopure), donor090612, donation3	12184-129A6	125.07	10.04	1.83	3.65
Wilms' tumor cell line:G-401	10809-111A8	66.24	27.39	4.93	2.22
Wilms' tumor cell line:HFWT	10597-108E3	26.40	7.04	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	118.43	16.76	3.07	0.28
achilles tendon, donor2	10292-104G4	70.26	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	80.57	11.22	1.78	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	114.93	19.04	2.32	3.95
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	169.87	23.39	1.54	2.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	163.81	23.40	12.52	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	61.56	7.59	1.41	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	125.62	34.89	4.02	3.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.08	7.35	3.27	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	74.91	9.69	2.20	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	150.68	85.76	16.74	12.25
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	87.37	17.86	6.21	7.77
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.41	8.28	4.23	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	148.22	66.31	27.30	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	109.92	42.06	6.51	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	164.40	59.81	9.32	9.58
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	124.79	58.45	7.31	6.72
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	85.52	12.08	3.25	3.72
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	119.67	34.96	6.17	8.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	61.08	14.43	4.60	3.38
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	91.74	27.31	3.41	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	103.12	31.85	3.03	6.98
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	121.07	38.99	4.09	6.74
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	50.34	5.57	1.78	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	167.77	46.70	3.00	3.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	146.80	29.73	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	110.36	31.26	4.52	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	133.89	44.05	7.41	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	121.84	43.11	11.25	3.75
adenocarcinoma cell line:IM95m	10796-110I4	187.46	36.27	2.83	4.24
adipose tissue, adult, pool1	10010-101C1	72.91	12.25	0.47	2.79
adipose, donor1	10184-103D4	53.95	15.83	0.00	2.35
adipose, donor2	10185-103D5	56.77	8.52	2.43	1.22
adipose, donor3	10186-103D6	47.38	5.72	1.91	1.09
adipose, donor4	10187-103D7	71.94	7.80	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	43.56	1.42	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	65.24	6.54	1.87	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	82.54	22.15	1.79	0.71
amniotic membrane cells, donor1	12235-129G3	94.36	22.72	2.09	0.93
amniotic membrane cells, donor2	12236-129G4	68.63	9.47	6.76	0.34
amniotic membrane cells, donor3	12237-129G5	96.33	7.95	1.47	1.18
amygdala - adult, donor10196	10167-103B5	27.27	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	39.13	3.85	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	28.08	4.20	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	59.46	16.81	1.53	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	99.72	47.43	0.88	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	41.42	11.36	0.00	1.34
aorta, adult, pool1	10052-101G7	59.43	4.51	0.39	0.59
appendix, adult	10189-103D9	112.17	21.35	1.94	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	67.41	20.64	5.16	3.10
artery, adult	10190-103E1	27.17	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	38.24	11.73	0.72	1.30
b cell line:RPMI1788	10427-106D4	69.44	11.15	4.46	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.40	19.98	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	89.51	86.23	2.38	3.97
bile duct carcinoma cell line:TFK-1	10496-107C1	51.89	25.44	0.67	3.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	142.61	150.99	3.36	5.59
bladder, adult, pool1	10011-101C2	76.48	9.99	0.98	1.20
blood, adult, pool1	10053-101G8	170.53	13.29	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	9.42	0.86	0.00
bone marrow, adult	10192-103E3	72.88	26.32	0.67	2.70
brain, adult, donor1	10084-102B3	25.63	2.05	2.05	0.00
brain, adult, pool1	10012-101C3	19.38	1.11	0.22	0.22
brain, fetal, pool1	10085-102B4	45.41	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	105.72	14.54	0.66	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.81	3.74	0.25	0.37
breast, adult, donor1	10080-102A8	74.50	6.94	0.63	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	76.98	11.18	6.10	2.54
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	141.31	29.07	9.28	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	46.50	13.35	1.84	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	88.12	20.58	5.08	0.48
carcinoid cell line:NCI-H1770	10703-109H1	40.43	3.29	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	75.91	29.86	1.86	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	45.95	1.58	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.42	7.99	0.80	2.13
caudate nucleus - adult, donor10196	10177-103C6	42.60	9.21	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	44.68	4.35	1.00	0.84
caudate nucleus, adult, donor10258	10379-105H1	40.50	5.35	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	46.51	10.25	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	93.22	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	52.31	4.06	0.64	0.64
cerebellum, adult, pool1	10083-102B2	30.36	1.03	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	78.05	9.13	0.83	1.66
cerebral meninges, adult	10188-103D8	18.66	3.28	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	11.69	5.85	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	48.31	8.63	2.59	2.73
cervical cancer cell line:ME-180	10553-107I4	171.19	73.25	11.93	4.47
cervix, adult, pool1	10013-101C4	77.06	11.86	0.94	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	47.10	35.11	1.95	3.20
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	5.23	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	186.17	146.77	11.18	13.30
choriocarcinoma cell line:SCH	10785-110H2	88.10	42.75	7.15	3.20
choriocarcinoma cell line:T3M-3	10618-108G6	109.10	50.99	2.61	2.37
chorionic membrane cells, donor1	12238-129G6	92.03	43.02	4.27	2.56
chorionic membrane cells, donor2	12239-129G7	49.22	23.07	1.59	1.89
chorionic membrane cells, donor3	12240-129G8	105.50	43.96	4.95	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	8.08	1.01	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	99.89	51.29	6.53	3.07
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	133.47	23.44	13.09	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	99.64	44.17	7.96	3.60
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	109.09	42.81	5.08	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	90.20	43.78	5.90	4.28
chronic myelogenous leukemia cell line:K562	10454-106G4	133.39	56.54	10.01	4.42
chronic myelogenous leukemia cell line:KU812	10409-106B4	189.47	70.37	9.12	6.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	73.60	24.00	2.97	0.69
clear cell carcinoma cell line:TEN	10636-108I6	45.63	19.78	1.74	0.87
colon carcinoma cell line:CACO-2	10513-107D9	106.16	82.73	2.93	4.94
colon carcinoma cell line:COLO-320	10420-106C6	103.38	23.95	7.60	2.28
colon, adult, donor1	10082-102B1	139.23	22.61	2.38	0.00
colon, adult, pool1	10014-101C5	75.44	23.62	1.41	5.88
colon, fetal, donor1	10070-101I7	150.79	32.75	4.33	3.09
common myeloid progenitor CMP, donor1	12130-128D6	87.09	4.58	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	47.17	33.14	1.27	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.43	11.32	0.30	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	28.48	12.13	0.14	0.99
corpus callosum, adult, pool1	10042-101F6	32.84	2.87	0.22	0.55
cruciate ligament, donor2	10295-104G7	57.54	12.16	1.62	2.43
diaphragm, fetal, donor1	10069-101I6	44.94	6.42	0.80	0.80
diencephalon, adult	10193-103E4	12.96	1.20	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.23	5.74	2.30	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	125.40	36.93	2.56	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	52.24	8.43	0.48	0.48
ductus deferens, adult	10196-103E7	69.77	12.46	4.98	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	120.98	31.69	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	77.24	18.39	1.47	0.74
dura mater, adult, donor1	10041-101F5	87.54	12.72	0.25	3.72
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.66	11.99	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.08	9.89	0.57	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	12.95	3.08	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	63.57	9.69	2.42	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	59.28	20.69	3.09	0.62
embryonic pancreas cell line:2C6	10603-108E9	48.60	9.19	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	110.61	37.54	2.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	59.08	9.97	1.09	2.90
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	54.03	8.36	2.41	0.16
epidermoid carcinoma cell line:A431	10426-106D3	183.75	52.80	6.11	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	139.57	84.91	3.63	3.63
epididymis, adult	10197-103E8	70.12	13.19	2.51	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	60.67	13.13	0.89	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	69.21	58.59	3.93	5.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	34.86	12.58	1.57	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.62	16.53	1.18	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	35.40	13.56	1.34	1.23
esophagus, adult, pool1	10015-101C6	112.65	26.97	2.23	2.97
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	57.11	2.25	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	43.46	19.32	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	39.98	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	43.16	13.39	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	22.93	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	52.47	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	36.86	5.08	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	42.31	11.41	2.31	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.00	9.50	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	28.62	2.63	0.09	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	218.58	120.70	1.80	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	108.99	56.69	1.55	1.74
gall bladder, adult	10198-103E9	61.32	9.66	1.45	2.41
gamma delta positive T cells, donor1	11937-126A2	153.54	5.37	4.29	0.54
gamma delta positive T cells, donor2	11938-126A3	153.13	9.34	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	57.03	20.91	1.90	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.00	23.79	3.48	2.71
gastric cancer cell line:AZ521	10549-107H9	73.12	17.05	2.13	1.97
gastric cancer cell line:GSS	10560-108A2	64.07	1.83	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	82.47	24.90	3.66	2.51
giant cell carcinoma cell line:LU65	10487-107B1	41.88	9.75	1.26	1.61
giant cell carcinoma cell line:Lu99B	10433-106E1	81.46	10.08	2.52	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	129.95	46.64	6.98	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	28.50	8.23	0.53	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.27	9.13	1.69	1.26
glioblastoma cell line:T98G	10485-107A8	47.02	17.22	1.99	1.10
glioma cell line:GI-1	10413-106B8	24.31	8.49	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	42.28	5.10	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	42.96	2.44	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	10.95	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	24.51	2.66	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	73.41	14.68	2.45	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	26.88	3.84	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	50.04	8.26	1.38	2.75
hIPS +CCl2, biol_rep2	14384-156C1	37.50	10.06	0.46	2.29
hIPS +CCl2, biol_rep3	14385-156C2	49.60	11.59	1.29	0.00
hIPS, biol_rep1	14380-156B6	15.81	31.62	1.44	1.44
hIPS, biol_rep2	14381-156B7	33.61	16.46	2.06	2.74
hIPS, biol_rep3	14382-156B8	14.35	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	65.51	4.31	1.72	0.29
heart - mitral valve, adult	10205-103F7	41.86	10.16	1.20	2.99
heart - pulmonic valve, adult	10206-103F8	32.42	4.97	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	70.77	31.64	1.67	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	46.93	9.18	3.47	0.41
heart, adult, diseased, donor1	10051-101G6	22.57	2.98	0.85	0.00
heart, adult, pool1	10016-101C7	29.44	2.99	0.46	0.46
heart, fetal, pool1	10046-101G1	56.06	8.83	0.72	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	54.61	13.88	0.93	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	66.59	28.54	1.19	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	81.21	35.80	5.19	3.98
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.86	34.96	5.46	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	85.29	36.99	6.06	2.73
hepatoma cell line:Li-7	10484-107A7	64.51	28.25	0.22	1.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	82.01	27.44	4.22	4.02
hippocampus - adult, donor10196	10169-103B7	20.82	3.79	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	29.80	2.45	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	17.43	3.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	29.96	3.88	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	85.45	26.24	0.61	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	77.95	15.90	1.18	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	78.96	14.98	1.52	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.43	14.10	1.13	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	78.50	13.94	0.52	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	61.88	13.29	0.38	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.35	11.68	1.46	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.95	9.05	1.94	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	58.39	15.43	3.75	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	35.52	9.71	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.09	10.13	1.45	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	7.41	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	89.04	22.85	1.72	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	58.46	24.56	2.95	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.07	19.20	0.87	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	82.09	16.61	1.15	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	63.23	13.52	1.31	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	60.97	10.00	0.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	60.10	7.91	0.75	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	73.21	9.55	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.19	7.83	2.51	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	31.03	6.04	0.65	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.06	4.64	0.87	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.37	3.29	1.79	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	60.97	10.35	2.96	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	66.76	12.84	1.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	72.27	20.82	2.04	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	52.81	18.31	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	49.41	12.99	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	60.83	14.83	0.61	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.30	4.65	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	49.15	4.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	33.86	4.87	1.80	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	35.02	8.44	1.79	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.89	9.09	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	46.38	9.41	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	62.55	13.52	1.21	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	56.60	17.83	4.01	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	70.24	17.07	2.93	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	56.84	12.84	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	32.53	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	68.17	15.55	0.33	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	10.40	2.19	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	52.84	11.22	0.72	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.91	12.46	1.78	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	28.64	3.58	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.63	12.19	0.81	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.33	7.54	1.35	1.08
immature langerhans cells, donor1	11904-125F5	91.77	26.64	3.87	4.12
immature langerhans cells, donor2	11905-125F6	110.90	26.14	2.38	4.75
insula, adult, pool1	10039-101F3	36.06	3.50	0.57	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	116.08	14.96	4.88	1.63
kidney, adult, pool1	10017-101C8	78.00	33.34	2.80	3.50
kidney, fetal, pool1	10045-101F9	142.82	76.11	4.53	4.31
large cell lung carcinoma cell line:IA-LM	10509-107D5	69.31	14.49	1.99	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	33.32	4.42	0.97	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	128.27	56.88	6.79	4.40
left atrium, adult, donor1	10079-102A7	41.95	5.99	0.54	1.09
left ventricle, adult, donor1	10078-102A6	33.88	3.03	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	63.48	6.84	2.19	0.55
leiomyoma cell line:10964C	10569-108B2	7.90	1.08	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	4.89	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	8.74	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	47.05	34.50	5.23	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	121.01	58.44	3.90	4.25
liposarcoma cell line:KMLS-1	10782-110G8	29.68	5.15	2.34	0.16
liposarcoma cell line:SW 872	10726-110A6	40.45	15.96	2.31	1.71
liver, adult, pool1	10018-101C9	33.71	7.29	1.13	1.30
liver, fetal, pool1	10086-102B5	54.56	8.47	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	32.52	3.50	0.00	0.44
locus coeruleus, adult, donor10252	10165-103B3	27.50	2.58	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	24.26	2.82	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	33.23	7.57	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	35.98	12.73	1.38	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	112.37	22.06	6.89	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	120.22	37.04	6.99	1.71
lung, adult, pool1	10019-101D1	99.58	12.64	1.30	2.95
lung, fetal, donor1	10068-101I5	171.53	22.26	2.28	2.28
lung, right lower lobe, adult, donor1	10075-102A3	107.22	19.70	1.37	2.29
lymph node, adult, donor1	10077-102A5	111.71	10.41	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	64.88	6.79	0.88	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	72.75	31.54	8.45	4.68
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	160.55	85.80	2.55	9.34
mature adipocyte, donor1	12231-129F8	19.98	2.66	1.33	0.89
mature adipocyte, donor2	12232-129F9	25.94	5.40	0.83	0.62
mature adipocyte, donor3	12233-129G1	16.83	5.22	0.24	0.95
mature adipocyte, donor4	12234-129G2	21.58	7.11	0.79	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	64.33	17.15	4.29	3.57
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	1.13	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.55	2.39	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	20.33	1.27	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	24.74	8.96	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	28.69	3.21	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	33.32	3.18	0.42	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	31.94	6.82	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	40.24	4.54	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	32.97	4.02	0.00	0.31
medulla oblongata, adult, pool1	10038-101F2	30.45	2.86	0.08	0.24
medulla oblongata, newborn, donor10223	10361-105F1	27.43	2.08	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	87.90	25.91	4.21	0.66
medulloblastoma cell line:ONS-76	10759-110E3	56.37	9.90	2.08	0.37
melanoma cell line:COLO 679	10514-107E1	26.74	12.65	0.29	0.72
melanoma cell line:G-361	10465-106H6	40.45	17.37	0.81	2.17
meningioma cell line:HKBMM	10691-109F7	48.48	20.80	4.34	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	48.46	4.41	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	58.33	6.48	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.48	5.68	0.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.27	2.36	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	3.31	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.78	2.95	0.56	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	19.26	6.16	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	3.47	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.73	4.12	0.17	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	19.09	3.34	0.92	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.15	4.24	0.27	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.82	5.81	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.46	8.39	0.28	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.07	2.63	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	27.95	8.16	0.28	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.55	5.59	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.11	4.08	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.16	8.99	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.76	3.72	0.31	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.73	5.70	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	32.31	5.03	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.07	4.18	1.20	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	23.02	6.65	0.61	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	1.84	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.19	11.45	1.14	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	38.73	22.31	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	3.20	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.65	2.81	0.00	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.58	1.83	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.41	4.01	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.42	3.53	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.95	3.05	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.61	1.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	21.32	4.63	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.05	3.75	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.85	1.78	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.95	3.85	0.00	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	28.60	5.13	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	2.01	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	2.46	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	1.62	0.00	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.99	3.73	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.99	3.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.93	2.72	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	4.74	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	1.22	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	21.54	3.17	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.83	1.72	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.34	1.87	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.70	9.90	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	12.34	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	23.53	14.63	1.27	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	21.76	6.45	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	13.08	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	7.28	1.82	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	4.94	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.81	6.75	0.40	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.52	6.49	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	3.87	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	85.05	17.01	2.13	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	115.14	82.71	13.67	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	64.10	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	55.79	130.90	1.85	5.75
mesothelioma cell line:Mero-25	10850-111F4	29.50	19.52	0.45	0.91
mesothelioma cell line:Mero-41	10851-111F5	43.76	12.96	0.73	1.47
mesothelioma cell line:Mero-48a	10852-111F6	44.95	28.34	4.65	2.88
mesothelioma cell line:Mero-82	10853-111F7	32.06	25.49	1.05	2.63
mesothelioma cell line:Mero-83	10854-111F8	46.13	25.87	1.70	2.04
mesothelioma cell line:Mero-84	10855-111F9	11.12	1.52	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	34.16	16.15	1.45	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	29.49	18.55	3.98	0.66
mesothelioma cell line:NCI-H226	10846-111E9	41.27	33.85	1.99	2.71
mesothelioma cell line:NCI-H2452	10848-111F2	38.44	8.88	1.20	0.68
mesothelioma cell line:NCI-H28	10845-111E8	76.09	38.68	2.29	2.80
mesothelioma cell line:No36	10857-111G2	15.98	6.85	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	43.62	43.08	3.79	4.88
migratory langerhans cells, donor1	11901-125F2	74.66	21.69	0.38	1.92
migratory langerhans cells, donor2	11902-125F3	74.73	20.15	1.34	2.69
migratory langerhans cells, donor3	11903-125F4	77.36	14.54	1.08	2.87
mixed mullerian tumor cell line:HTMMT	10689-109F5	50.60	19.92	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.43	6.36	1.27	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	72.10	26.95	2.07	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.08	23.22	1.33	4.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.99	20.14	3.70	4.44
myeloma cell line:PCM6	10474-106I6	106.34	16.21	1.78	4.35
myxofibrosarcoma cell line:MFH-ino	10600-108E6	45.66	14.71	3.55	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	42.56	5.49	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	74.43	10.14	1.78	1.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	62.29	14.86	1.47	1.32
nasal epithelial cells, donor2	12227-129F4	81.14	13.80	1.10	2.21
neuroblastoma cell line:CHP-134	10508-107D4	30.60	4.60	0.23	0.92
neuroblastoma cell line:NB-1	10539-107G8	47.52	5.24	0.56	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	12.23	1.90	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	37.83	6.34	0.56	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	28.94	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.83	1.27	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	17.31	1.81	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.89	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	50.57	9.58	0.00	0.53
neutrophil PMN, donor1	12133-128D9	133.87	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	225.77	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	170.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	106.71	22.32	4.06	5.58
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	39.22	5.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.71	6.73	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.67	20.50	2.63	0.53
nucleus accumbens, adult, pool1	10037-101F1	38.53	3.66	0.28	0.37
occipital cortex - adult, donor10196	10172-103C1	14.42	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	38.91	2.15	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	29.12	6.19	0.73	1.09
occipital lobe, adult, donor1	10076-102A4	19.94	3.15	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	100.41	3.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	19.16	1.02	0.08	0.16
olfactory region, adult	10195-103E6	21.02	1.15	0.00	0.00
optic nerve, donor1	10277-104E7	24.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	171.66	74.15	24.15	4.10
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	154.97	11.68	5.63	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	98.89	23.54	2.03	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	81.55	22.76	1.73	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	62.32	13.23	2.06	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	12.15	0.93	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	9.12	2.76	0.00	0.42
ovary, adult, pool1	10020-101D2	46.03	7.95	0.17	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	60.86	17.23	1.65	1.28
pancreas, adult, donor1	10049-101G4	61.14	6.58	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	126.91	96.44	8.39	9.50
papillary adenocarcinoma cell line:8505C	10437-106E5	52.81	36.46	1.87	3.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	291.59	165.25	8.11	7.29
paracentral gyrus, adult, pool1	10035-101E8	24.25	2.56	0.27	0.27
parietal cortex, adult, donor10258	10373-105G4	12.48	1.47	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	16.93	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	29.64	2.85	0.29	1.43
parietal lobe, adult, pool1	10034-101E7	23.97	2.11	0.18	0.26
parietal lobe, fetal, donor1	10072-101I9	92.13	7.76	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	29.91	6.73	1.87	0.75
parotid gland, adult	10199-103F1	38.23	7.40	0.62	1.23
penis, adult	10200-103F2	43.51	5.37	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.07	2.60	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	74.45	16.46	2.77	2.19
pineal gland - adult, donor10196	10179-103C8	58.05	14.84	7.10	0.65
pineal gland, adult, donor10252	10160-103A7	81.13	14.21	2.96	0.59
pineal gland, adult, donor10258	10377-105G8	38.25	4.39	3.76	0.00
pituitary gland - adult, donor10196	10180-103C9	75.89	10.12	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	120.91	23.45	9.38	1.56
pituitary gland, adult, donor10258	10378-105G9	61.29	9.36	3.40	0.00
placenta, adult, pool1	10021-101D3	75.90	22.36	1.72	2.47
plasma cell leukemia cell line:ARH-77	10840-111E3	76.94	25.56	5.30	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	82.33	10.58	3.74	1.09
pons, adult, pool1	10033-101E6	19.80	1.98	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	18.66	1.13	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	86.23	41.22	5.39	1.89
prostate cancer cell line:PC-3	10439-106E7	83.31	20.51	1.09	2.00
prostate, adult, pool1	10022-101D4	53.78	6.71	0.54	0.91
putamen, adult, donor10196	10176-103C5	37.06	2.36	0.71	0.71
putamen, adult, donor10252	10152-102I8	43.14	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	12.02	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	27.54	3.38	0.48	0.24
putamen, newborn, donor10223	10365-105F5	32.24	6.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	92.81	31.42	1.45	2.91
rectum, fetal, donor1	10067-101I4	141.88	18.08	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	83.53	37.74	5.72	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	206.28	54.68	8.28	0.41
retina, adult, pool1	10030-101E3	44.03	5.96	0.60	1.09
retinoblastoma cell line:Y79	10475-106I7	38.97	9.87	0.26	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	39.22	9.59	1.60	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	91.95	26.71	0.56	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	3.03	0.00	1.52
salivary acinar cells, donor1	11771-123I7	31.40	5.34	1.46	0.16
salivary acinar cells, donor2	11772-123I8	32.49	3.30	5.23	1.38
salivary acinar cells, donor3	11773-123I9	37.74	7.94	3.31	0.00
salivary gland, adult, pool1	10093-102C3	75.50	16.01	2.86	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.62	10.03	1.94	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	44.08	9.05	2.00	1.53
seminal vesicle, adult	10201-103F3	92.06	8.99	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	64.13	21.62	2.43	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.75	10.82	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	14.05	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	68.23	8.73	1.21	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	83.23	24.21	0.22	3.54
signet ring carcinoma cell line:NUGC-4	10483-107A6	61.93	15.61	0.90	1.81
skeletal muscle - soleus muscle, donor1	10282-104F3	27.66	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	24.35	3.96	0.48	1.56
skeletal muscle, fetal, donor1	10066-101I3	45.23	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	81.42	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	82.06	11.99	0.63	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	171.10	51.70	11.67	6.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	186.92	113.79	14.50	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	30.26	2.31	0.00	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	111.92	33.30	10.88	4.29
small cell lung carcinoma cell line:NCI-H82	10842-111E5	65.79	9.65	1.45	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	108.96	38.14	3.70	2.62
small intestine, adult, pool1	10024-101D6	113.83	49.09	0.60	10.03
small intestine, fetal, donor1	10064-101I1	82.31	10.32	0.25	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	136.94	23.59	7.69	6.15
smooth muscle, adult, pool1	10048-101G3	41.35	6.20	0.26	1.03
somatostatinoma cell line:QGP-1	10781-110G7	121.41	12.60	3.22	2.68
spinal cord - adult, donor10196	10181-103D1	51.16	5.96	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	63.48	6.70	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	17.99	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	54.28	4.27	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	21.58	5.97	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.97	10.16	0.45	0.60
spleen, adult, pool1	10025-101D7	83.59	12.00	0.66	2.64
spleen, fetal, pool1	10044-101F8	98.68	20.02	0.79	1.59
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.07	8.70	9.11	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	215.51	33.23	3.99	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	43.68	16.42	5.59	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	108.68	50.43	8.21	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	100.63	41.42	7.77	3.04
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	58.03	7.62	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	43.58	32.58	2.96	2.54
stomach, fetal, donor1	10062-101H8	178.35	18.16	6.41	2.14
submaxillary gland, adult	10202-103F4	72.35	15.38	3.99	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	32.61	2.28	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	13.97	2.07	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	7.07	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	62.36	9.63	2.52	1.15
temporal lobe, adult, pool1	10031-101E4	20.34	1.02	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.21	3.56	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	53.62	5.27	0.44	0.44
tenocyte, donor1	11763-123H8	22.69	3.84	0.35	0.35
tenocyte, donor2	11765-123I1	15.26	6.49	0.38	0.38
tenocyte, donor3	11768-123I4	19.65	3.71	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	63.74	16.15	1.70	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	98.50	21.12	2.93	2.16
teratocarcinoma cell line:PA-1	10807-111A6	142.27	31.00	5.89	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	113.49	40.62	3.68	3.55
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	88.11	43.11	0.76	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.54	19.41	4.25	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	100.32	29.31	0.33	4.23
testis, adult, pool1	10026-101D8	88.80	16.75	6.01	2.36
testis, adult, pool2	10096-102C6	97.89	23.01	16.24	0.45
thalamus - adult, donor10196	10168-103B6	29.81	6.62	1.10	0.00
thalamus, adult, donor10252	10154-103A1	36.73	3.59	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.95	1.32	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	12.08	2.30	0.00	0.58
throat, adult	10209-103G2	66.66	15.48	0.50	2.25
throat, fetal, donor1	10061-101H7	78.31	8.84	1.83	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	52.66	3.18	0.99	0.20
thymus, adult, pool1	10027-101D9	175.57	11.43	1.19	2.19
thymus, fetal, pool1	10043-101F7	175.91	15.90	1.66	1.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.77	44.94	2.13	2.93
thyroid carcinoma cell line:TCO-1	10783-110G9	73.48	21.51	2.10	2.10
thyroid, adult, pool1	10028-101E1	47.87	8.96	0.84	1.12
thyroid, fetal, donor1	10060-101H6	70.40	6.33	0.79	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	15.40	3.08	0.00
tongue, adult	10203-103F5	89.08	23.03	1.63	1.63
tongue, fetal, donor1	10059-101H5	40.99	4.73	1.58	0.00
tonsil, adult, pool1	10047-101G2	165.99	28.75	1.80	3.21
trachea, adult, pool1	10029-101E2	83.27	19.06	1.96	2.13
trachea, fetal, donor1	10058-101H4	61.55	10.00	0.77	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	31.88	6.02	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	95.14	36.88	1.11	2.84
transitional-cell carcinoma cell line:JMSU1	10492-107B6	125.98	65.50	2.82	4.54
tridermal teratoma cell line:HGRT	10694-109G1	20.93	5.71	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.22	13.29	2.79	1.52
umbilical cord, fetal, donor1	10057-101H3	35.47	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	71.49	6.31	0.51	2.22
uterus, fetal, donor1	10055-101H1	58.87	7.17	1.02	1.54
vagina, adult	10204-103F6	69.79	8.40	0.65	2.58
vein, adult	10191-103E2	89.65	7.67	0.22	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	51.81	12.82	4.54	1.07